We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG

By HospiMedica International staff writers
Posted on 12 Oct 2026

Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. More...

These studies routinely record electrocardiogram signals, but the data are rarely used to assess long-term cardiovascular risk. To make better use of these signals, researchers have developed a deep learning approach that analyzes sleep-study electrocardiograms to predict future cardiovascular outcomes.

A National Institutes of Health (NiH)-supported research team evaluated a deep learning model that analyzes single-lead electrocardiograms from overnight polysomnography. The model combines the electrocardiogram signal with expert-annotated sleep stage information. It was designed to estimate 10-year risk for cardiovascular outcomes, including atrial fibrillation, stroke, myocardial infarction, heart failure, and all-cause mortality.

The model was fine-tuned using data from 15,809 patients at Massachusetts General Hospital in Boston. Its performance was then assessed in two separate data sets that included 9,810 patients from Emory University Hospital in Atlanta and 12,576 patients from Beth Israel Deaconess Medical Center in Boston. The outcomes were derived from electronic health records.

The system separated patients into groups with different levels of long-term cardiovascular risk. Higher model scores were associated with higher risk. The model retained predictive value after adjustment for age, sex, body mass index, diabetes, hypertension, sleep apnea severity, arousals, and sleep efficiency.

The model predicted atrial fibrillation, heart failure, and death from any cause. The investigators reported that additional optimization is needed for myocardial infarction and stroke prediction. The findings were published in SLEEP on October 9, 2026, and the approach may be feasible because it uses a single electrocardiogram lead rather than a standard 12-lead setup.

“Importantly, we found that adding the score from our deep learning model improved prediction of cardiac outcomes beyond established risk factors. Adding these scores into sleep studies has great potential for improving early detection of cardiovascular disease, determining who is most at risk and being more proactive in patient care,” said Gari Clifford, D.Phil., study author, chair of the Department of Biomedical Informatics at Emory University School of Medicine and professor of biomedical engineering at Georgia Institute of Technology.

Related Links
National Institutes of Health


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.